CELZ Creative Medical Technology
- 4.3401
- -0.0599-1.36%
Creative Medical Technology News
Creative Medical Technology | 10-Q: Quarterly report
Creative Medical Technology Holdings Provides Corporate Update
Creative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
BREA, MSAI and APM Among Pre-market Losers
Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?
Thursday, Creative Medical Technology Holdings Inc (NASDAQ:CELZ) secured FDA authorization for an expanded access therapy using CELZ-201, a cell-based program to manage abnormal glucose tolerance and
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersPsyence Biomedical (NASDAQ:PBM) stock moved upwards by 35.3% to $1.38 during Thursday's regular session. The market value of their outstanding shares is at $18.4 million. ZyVersa Therapeutics (
Creative Medical Stock Rallies for Second Day on FDA Updates
Creative Medical Shares Rise 37% After FDA Authorization for CELZ-201
By Chris Wack Creative Medical Technology Holdings shares were up 37% at $6.50 after the company said it received Food and Drug Administration authorization for an expanded access therapy using CELZ-
Viking Therapeutics, Creative Medical Technology, Aptorum Group Among Healthcare Movers
Creative Medical Technology Skyrockets on Word of New Diabetes Medication
Creative Medical Technology Shares Halted On Circuit Breaker, Up 85%
Creative Medical Technology Shares Halted On Circuit Breaker, Up 85%
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ), a leader in biotech innovation, today announced a major stride in combating Type 1 Diabetes Mellitus (T1D). The company has secured FDA authorization for an
Biotech Finds Mid-Week Success Following FDA Announcement
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersSCWorx (NASDAQ:WORX) stock increased by 60.8% to $2.75 during Wednesday's after-market session. The market value of their outstanding shares is at $3.3 million. IO Biotech (NASDAQ:IOBT) stock i
Creative Medical Technology (CELZ) Stock Soars In Response To New Drug Clearance
Presently in the current trading session, Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) is experiencing a notable surge, marking a 22.80% increase to $5.00 as per the latest update. This uptrend in CELZ stock correlates with the regulatory clearance obtained for a novel pharmaceutical product by the company. The U.S. Food and Drug Administration (FDA) ...
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Ahead of Powell Testimony
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.6% and the actively traded Invesco QQQ Trust (QQQ) was 0.8% higher in Wednesday's premarket activity, as traders hope that F
DADA, IFBD and LASE Among Mid-day Gainers
Creative Medical Shares Rally Premarket on FDA Orphan Designation
By Colin Kellaher Shares of Creative Medical Technology Holdings jumped nearly 30% in premarket trading Wednesday after the biotechnology company said it won U.S. Food and Drug Administration orphan-
Market-Moving News for March 6th
CRWD: 27% | CrowdStrike Holdings shares are trading higher after the company reported better-than-expected Q4 earnings and revenues and issued upbeat guidance for Q1 and FY25. Some analysts raised the
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNKGen Biotech (NASDAQ:NKGN) shares increased by 69.4% to $1.46 during Wednesday's pre-market session. The market value of their outstanding shares is at $31.9 million. Creative Medical Tech (NA
Analysis
Price Target
No Data
